Coming from a strategic advisory background, Sri has worked with biopharma and digital health clients across a variety of key business issues ranging from pricing, market access to portfolio strategy and forecasting. He continues to leverage Real-World Evidence (RWE) in driving strategic insights for some of the most disruptive business questions and has pioneered projects in benchmarking digital / data capabilities, commercial forecasting, evidence generation, value-based contracting and longitudinal patient flow modeling in oncology. By driving commercial-focused insights, Sri enables his clients to translate a complex organizational mandate into clear strategic vision in a global setting. ​

Sri has an M.B.A. & M.S. from Boston University and a B.E. in Computer Engineering from the National University of Singapore.